Beam Therapeutics Inc.
(BEAM)
undefined
undefined%
At close: undefined
28.00
0.32%
After-hours Dec 13, 2024, 04:29 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 377.71M | 60.92M | 51.84M | 24.00K | 18.00K | - | - |
| Cost of Revenue | 437.38M | 22.58M | 16.44M | 103.18M | 5.41M | 650.00K | 11.00K |
| Gross Profit | -59.67M | 38.34M | 35.40M | -103.16M | -5.39M | -650.00K | -11.00K |
| Operating Income | -176.49M | -338.48M | -392.46M | -132.76M | -75.15M | -45.74M | -7.88M |
| Interest Income | - | 15.30M | 9.00K | 1.57M | 2.49M | 292.00K | - |
| Pretax Income | -131.16M | -260.18M | -370.64M | -194.59M | -78.33M | -116.74M | -8.00M |
| Net Income | -132.53M | -263.59M | -341.36M | -256.42M | -78.44M | -115.26M | -8.00M |
| Selling & General & Admin | 116.81M | 87.81M | 57.22M | 29.61M | 20.55M | 11.87M | 2.02M |
| Research & Development | 437.38M | 311.59M | 387.09M | 103.18M | 54.62M | 33.87M | 5.86M |
| Other Expenses | - | - | - | - | -71.00K | -10.04M | 378.00K |
| Operating Expenses | 554.19M | 399.40M | 444.31M | 132.78M | 75.17M | 45.74M | 7.88M |
| Interest Expense | - | 15.30M | 9.00K | 1.57M | 187.00K | - | - |
| Selling & Marketing Expenses | - | - | - | - | - | - | - |
| Cost & Expenses | 554.19M | 399.40M | 444.31M | 132.78M | 75.17M | 45.74M | 7.88M |
| Income Tax | 1.37M | 3.41M | -29.28M | 61.83M | 116.00K | -71.00M | 500.00K |
| Shares Outstanding (Basic) | 77.15M | 70.02M | 64.23M | 46.73M | 51.34M | 35.14M | 12.95M |
| Shares Outstanding (Diluted) | 77.15M | 70.02M | 64.23M | 46.73M | 51.34M | 35.14M | 12.95M |
| EPS (Basic) | -1.72 | -3.76 | -5.31 | -5.49 | -1.53 | -3.28 | -0.62 |
| EPS (Diluted) | -1.72 | -3.76 | -5.31 | -5.49 | -1.53 | -3.28 | -0.62 |
| EBITDA | -156.47M | -324.33M | -392.46M | -128.03M | -71.65M | -45.09M | -7.99M |
| Depreciation & Amortization | 20.01M | 22.58M | 16.44M | 9.47M | 5.41M | 650.00K | 11.00K |